Prospective Study to Ascertain the Advantages of Adding Neprilysin Inhibitor to Standard Care Among Patients with Congestive Cardiac Failure. ijmhs [Internet]. 2022 May 27 [cited 2026 Oct. 23];12(05):1903-9. Available from: http://innovativejournal.in/index.php/ijmhs/article/view/3440